In the BioHarmony Drug Report Database
Calcipotriene
Dovonex, Sorilux (calcipotriene) is a small molecule pharmaceutical. Calcipotriene was first approved as Dovonex on 1993-12-29. It is used to treat psoriasis in the USA. The pharmaceutical is active against vitamin D3 receptor. Calcipotriene’s patents are valid until 2028-05-07 (FDA).
Trade Name
|
Dovonex, Sorilux |
|---|---|
Common Name
|
calcipotriene |
ChEMBL ID
|
CHEMBL1200666 |
Indication
|
psoriasis |
Drug Class
|
Vitamin D analogues |
Image (chem structure or protein)